ZMapp, experimental Ebola drug, falls short in clinical trial that couldn't find enough new patients
Thursday, October 13, 2016 - 06:52
in Health & Medicine
ZMapp was perhaps the most sought-after drug at the height of the Ebola crisis, but a clinical trial has failed to prove that patients who got the experimental medication were helped by it. Among 36 patients who were randomly assigned to receive ZMapp in addition to the standard therapy available...